These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8345720)

  • 21. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
    Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T
    Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
    Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
    Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
    Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.
    Koretz K; Moldenhauer G; Majdic O; Möller P
    Int J Cancer; 1989 Nov; 44(5):816-22. PubMed ID: 2583862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of major histocompatibility complex (MHC) antigens and their loss on culture in renal carcinoma.
    Angus R; Collins CM; Symes MO
    Eur J Cancer; 1993; 29A(15):2158-60. PubMed ID: 8297657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
    Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
    Ryschich E; Autschbach F; Eisold S; Klar E; Buchler MW; Schmidt J
    Tissue Antigens; 2003 Jul; 62(1):48-54. PubMed ID: 12859594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer.
    Tomita Y; Nishiyama T; Fujiwara M; Sato S
    Br J Cancer; 1990 Sep; 62(3):354-9. PubMed ID: 2206942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reaction patterns of tumor infiltrating lymphocytes in different renal cell carcinomas and oncocytomas.
    Störkel S; Keymer R; Steinbach F; Thoenes W
    Prog Clin Biol Res; 1992; 378():217-23. PubMed ID: 1363795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression on major histocompatibility complex antigen and effect of IFN-alpha on renal cell carcinoma].
    Nagata M
    Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):814-21. PubMed ID: 8320886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
    Momburg F; Koretz K; Von Herbay A; Möller P
    Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of class I and class II histocompatibility antigens in inflammatory kidney diseases].
    Eberlein-Gonska M; Sill H; Waldherr R
    Verh Dtsch Ges Pathol; 1989; 73():117-23. PubMed ID: 2482595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.